Response by Dhingra et al to Letter Regarding Article, "proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy"

Rimpy Dhingra; Ali Javaheri; Abhinav Diwan; Lorrie A. Kirshenbaum

doi:10.1161/CIRCULATIONAHA.123.063546

Response by Dhingra et al to Letter Regarding Article, "proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy"

Rimpy Dhingra, Ali Javaheri, Abhinav Diwan, Lorrie A. Kirshenbaum

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1051-1052
Number of pages	2
Journal	Circulation
Volume	147
Issue number	13
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.123.063546
State	Published - Mar 28 2023

Access to Document

10.1161/CIRCULATIONAHA.123.063546

Cite this

@article{51404d372c994bd286e22679fd7513e5,

title = "Response by Dhingra et al to Letter Regarding Article, {"}proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy{"}",

author = "Rimpy Dhingra and Ali Javaheri and Abhinav Diwan and Kirshenbaum, {Lorrie A.}",

note = "Funding Information: This work was supported by a Foundation grant (FRN-42402) to L.A.K. from the Canadian Institute for Health Research (CIHR), L.A.K. holds a Canada Research Chair in Molecular Cardiology. This study was also supported by grants from the National Institutes of Health (HL107594 and HL143431) and the Department of Veterans Affairs (I01BX004235) to A.D. A..J. was supported by K08HL138262 and IR01HL155344 from the NHLBI and by the Children's Discovery Institute of Washington University (MC-FR-2020-919) and St. Louis Children's Hospital. ",

year = "2023",

month = mar,

day = "28",

doi = "10.1161/CIRCULATIONAHA.123.063546",

language = "English",

volume = "147",

pages = "1051--1052",

journal = "Circulation",

issn = "0009-7322",

number = "13",

}

TY - JOUR

T1 - Response by Dhingra et al to Letter Regarding Article, "proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy"

AU - Dhingra, Rimpy

AU - Javaheri, Ali

AU - Diwan, Abhinav

AU - Kirshenbaum, Lorrie A.

N1 - Funding Information: This work was supported by a Foundation grant (FRN-42402) to L.A.K. from the Canadian Institute for Health Research (CIHR), L.A.K. holds a Canada Research Chair in Molecular Cardiology. This study was also supported by grants from the National Institutes of Health (HL107594 and HL143431) and the Department of Veterans Affairs (I01BX004235) to A.D. A..J. was supported by K08HL138262 and IR01HL155344 from the NHLBI and by the Children's Discovery Institute of Washington University (MC-FR-2020-919) and St. Louis Children's Hospital.

PY - 2023/3/28

Y1 - 2023/3/28

UR - http://www.scopus.com/inward/record.url?scp=85150999679&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.123.063546

DO - 10.1161/CIRCULATIONAHA.123.063546

M3 - Letter

C2 - 36972342

AN - SCOPUS:85150999679

SN - 0009-7322

VL - 147

SP - 1051

EP - 1052

JO - Circulation

JF - Circulation

IS - 13

ER -

Response by Dhingra et al to Letter Regarding Article, "proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy"

Access to Document

Other files and links

Cite this